US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on Oct. 28 for "Anti-CD79B antibodies and chimeric antigen receptors and methods of use thereof" (Texas Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,574, issued on Oct. 28, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"Anti-CD79B antibodies and chimeric antigen receptors and methods of use thereof" was invented by Fuliang Chu (Houston), Sattva S. Neelapu (Houston), JingJing Cao (Houston) and Jingwei Liu (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are CD79b antibodies and CD79b-specific chimeric antigen receptors (CARs). Further provided herein are T cells expressing the CD79b-specific CARs and methods of treating cancer by administering the CD79b-specific CAR T cells."

The patent was filed on Oct. 30, 2019, under Application No. 1...